Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
55.52 +0.38  +0.69% NYSE Apr 24, 4:59PM BATS Real time Currency in USD
View Full Chart
GSK Price Chart
View All Events

GSK Events

Date Type Description
Oct 22 Earnings GlaxoSmithKline PLC 2013 Third Quarter Earnings Results. Estimate: 0.72.
Jul 23 Earnings GlaxoSmithKline PLC 2013 Second Quarter Earnings Results. Estimate: 0.72.
May 07 Misc AGM Event for GlaxoSmithKline PLC
Feb 27 Misc Annual Report for GlaxoSmithKline PLC
Feb 19 Dividends Amount: 0.7496, Declared Date: Feb 05 2014, Pay Date: Apr 10 2014
Feb 05 Earnings GlaxoSmithKline PLC Q4 2013 Earnings Results. Estimate: 1.00.
Feb 05 Misc GlaxoSmithKline PLC Q4 2013 Earnings Conference Call
Jan 09 Misc Payment Date of Q3 Dividend
Nov 13 Dividends Amount: 0.6161, Declared Date: Oct 24 2013, Pay Date: Jan 09 2014
Oct 23 Earnings Q3 2013 Earnings Release. Estimate: 0.90.
View All Performance Charts

GSK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GlaxoSmithKline is up 13.80% over the last year vs S&P 500 Total Return up 21.54%, AstraZeneca up 39.09%, and Johnson & Johnson up 20.45%.

Get Quote for

PDF Report for GSK

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download GSK Pro Report PDF
Advertisement

Portfolio Strategies Featuring GSK

Did GlaxoSmithKline make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GSK Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Headquarters Country: United Kingdom
  • Headquarters State/Province: N/A
  • Incorporation Country: United Kingdom
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

GlaxoSmithKline plc, often abbreviated to GSK, is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world's third largest pharmaceutical company measured by revenues (after Johnson & Johnson and Pfizer). It has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions.As one of the world's top prescription drug makers, GlaxoSmithKline enjoys annual revenues that exceed 13.2 billion. GSK was formed in 2000 by the merger of GlaxoWellcome plc (formed from the acquisition of Wellcome plc by Glaxo plc), and SmithKline Beecham plc (from the merger of Beecham plc, and SmithKlineBeckman Corporation). GlaxoSmithKline plc was founded in 1999 and is headquartered in Brentford, United Kingdom.

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 55.52 +0.38 +0.69% 134.77B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.